GlassScriptPhysician profile
Timothy J Juelson
NPI 1174569826
$2,588.67
in general payments reported to CMS, 2019-2025
22 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $244 · 2021: $292 · 2022: $432 · 2023: $422 · 2024: $407 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.52 |
| Education | $182.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $886.46 | 2019-2024 | Fms, Vapr |
| Stryker Corporation | $428.19 | 2023-2024 | Alphavent, Vsp System, Vsp Cranial, Salvation |
| Smith+Nephew, INC. | $267.50 | 2019-2025 | Pico, Pico 7, Grafix Pl |
| Vericel Corporation | $261.99 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $98.71 | 2025 | |
| Joint Restoration Foundation, INC. | $85.99 | 2025 | |
| Amgen INC. | $70.80 | 2019-2024 | Evenity, Prolia |
| Sioux Surgical INC | $64.59 | 2022-2023 | |
| Ethicon US, LLC | $63.50 | 2025 | Dermabond, Stratafix |
| Sanofi-Aventis U.S. LLC | $58.01 | 2019 | |
| Pacira Therapeutics, INC. | $53.51 | 2019 | |
| Integra Lifesciences Corporation | $46.09 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Pharmaceuticals Incorporated | $34.47 | 2023 | Iovera |
| Ipsen Biopharmaceuticals, INC | $33.66 | 2023 | Sohonos |
| Kerecis Limited | $21.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.39 | 2020 | |
| Convatec INC. | $18.74 | 2024 | |
| Pfizer INC. | $18.60 | 2025 | |
| Avanos Medical | $15.42 | 2023 | On-Q* Pump and Accessories |
| Endo Pharmaceuticals INC. | $13.70 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.41 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.01 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Juelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.